Results

Total Results: 635 records

Showing results for "rapid response".

481. Treatment for Restless Legs Syndrome: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
     February 01, 2013 - ES-2 reduced RLS symptoms, increased the percentage of patients with a clinically important response … and etiology of disease, age, obesity, and other characteristics that appear to have an effect on response … rotigotine) reduced RLS symptoms, increased the percentage of patients with a clinically important response … evidence demonstrated that pregabalin increased the percentage of patients with a clinically important response … stakeholders to clarify or supplement the call summaries or to suggest additional research questions in response

482. Options for Developing a Web-Based Forum on Patient Registries (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/registries-forums_research_0.pdf
     May 01, 2014 - It is a collaborative network of research centers that support the rapid development of new scientific … the meeting on a first-come basis, but invitations for some categories of stakeholders with a strong response … The response to the stakeholder meeting invitation was very strong; all in-person attendee spots were … that allows users to assign a value to an item that reflects their positive (and sometimes negative) response … , it may be worth determining how AHRQ policy will apply to these situations, and the appropriate response

483. Restless-Legs Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
     November 01, 2012 - • There is limited indirect comparison evidence that the effect on clinically important response may … Most studies used flexible up-titration based on symptom response and adverse effects, with doses ranging … Compared with placebo, the percentage of patients with a favorable treatment response was greater with … studies as the basis for increasing drug doses or altering administration timing if symptom response … Moreover, clinicians and patients should be aware of such a large placebo response.

484. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
     June 01, 2010 - the public comment period, comparative effectiveness research reviews are revised by the authors in response … The table below includes the response by the authors of the review to each comment submitted for the … Source: www.effectivehealthcare.ahrq.gov Published Online June 1, 2010 Section Comment Response … The (admittedly informal) response I have gotten is that 80% of patients in the US are off-label, but … In trauma, uncontrolled bleeding leads to rapid death.

485. Research White Paper Registries in Accountable Care Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/accountable-care-registries-guide-3rd-ed-addendum-white-paper-2018-5.pdf
     January 01, 2018 - ACO registries can also be used for rapid cycle patient-oriented outcomes research, efforts that are

486. Breast-Abnormalities-Tests-Update Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-abnormalities-tests-update_research-protocol.pdf
     July 01, 2010 - Background and Objectives In response to Section 1013 of the Medicare Modernization Act, the Agency … asymptomatic women; breast cancer staging; evaluation for a possible recurrence of breast cancer; monitoring response

487. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
     January 01, 2013 - may seem to be a natural choice when there is a dramatic s hift from one treatment to another (e.g., rapid … Evaluation of response time data involving transient states: an illustration using heart-transplant data

488. Assessing Applicability (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
     January 01, 2009 - period: attrition rate before randomization and reasons (e.g., nonadherence, adverse drug events, no response … If high levels of nonadherence, adverse effects, or lack of response are found, then this reduces applicability

489. MEDICAL MANAGEMENT OF CONGESTIVE HEART FAILURE AND THE EFFECTIVENESS OF ISOSORBIDE DINITRATE AND HYDRALAZINE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
     March 01, 2010 - It is a collaborative network of research centers that support the rapid development of new scientific … hydralazine/isosorbide dinitrate (H-ISDN) combination* VARIABLE GROUP Variable Categorical response

490. Glaucoma-Treatment Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_surveillance.pdf
     January 01, 2013 - Assessment of the Need to Update Comparative Effectiveness Reviews: Report of an Initial Rapid Program

491. FRN 29: Future Research Needs on Procalcitonin-Guided Antibiotic Therapy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
     August 01, 2014 - from draft CER for procalcitonin as a diagnostic indicator for infection and as an indicator of response … from draft CER for procalcitonin as a diagnostic indicator for infection and as an indicator of response … The response rate was 100 percent (n=9); 8 (of 10) research needs received votes. … The response rate was 100 percent (n=9); all questions received votes. … Host cytokine response affects PCT levels, so PCT cut-offs may differ in these populations.

492. Microsoft Word - cognitive-decline-protocol-160322.docx (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
     March 22, 2016 - Other factors that may be considered in assessing strength of evidence include dose-response relationship

493. Methods Guide for Medical Test Reviews Chapter 12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-prognostic_methods.pdf
     July 01, 2012 - Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy

494. Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
     April 01, 2010 - It is a collaborative network of research centers that support the rapid development of new scientific … plan for depression should be documented If a patient with cancer is treated for depression, then response

495. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
     December 11, 2012 - Ticagrelor is a reversible P2Y12 receptor antagonist that, when compared with clopidogrel, provides a more rapid … Initial pharmacokinetic/pharmacodynamic studies have suggested a reduction in the antiplatelet response … Based on comments received in response to this posting, the following change was made to the KQs: … Additionally, when appropriate, the studies will be evaluated for dose-response association, the presence

496. GRADING THE STRENGTH OF A BODY OF EVIDENCE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-grading-evidence_methods.pdf
     November 01, 2013 - considered for some bodies of evidence and increase confidence in the findings include increasing dose-response … required, domains are most relevant to bodies of evidence consisting of observational studies: dose-response … The second set of domains, which supplement the five required domains, has three components: dose-response … Score as one of two levels: • Present: Dose-response pattern observed • Undetected: No dose-response … pattern observed (dose-response relationship not present or could not be determined) Plausible

497. Functional-Limitations-Horizon-Scan-High-Impact-1306 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - If C1INH is deficient, an acute inflammatory response occurs that leads to swelling, which is the … If C1INH is deficient, C1 proteases set off the complement pathway, causing an acute inflammatory response … Part of the inflammatory response is the release of uncontrolled levels of bradykinin (BK), a potent … The combination of rapid relief of symptoms and self-administration is expected to improve health outcomes … the retina using tests for refraction, color vision, visual field, visual acuity, and pupil-reflex response

498. Labor-Nitrous-Oxide Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_executive.pdf
     August 01, 2012 - Nitrous oxide has a rapid onset and end of action.

499. DEcIDE 32: The Incident User Design in Comparative Effectiveness Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
     May 01, 2012 - It is a collaborative network of research centers that support the rapid development of new scientific … early events, especially treatment discontinuations, because of problems with tolerability or poor response … Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis: results from

500. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-adherence-interventions_research-protocol.pdf
     August 18, 2011 - helping patients to better adhere to recommended treatment. 4-6 Over the past half century, rapid … and alternatives to the prescribed medication; and lack of access to a provider who will monitor the response … It also considers other optional domains that may be relevant for some scenarios, such as a dose-response